Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
CompareHealth Care

Processa Pharmaceuticals, Inc. vs Natera, Inc.

PCSA and NTRA side by side: what insiders, tracked funds and members of Congress reported about each stock. Insiders put more of their own money into Processa Pharmaceuticals, Inc. over the past year ($209K).

at prices of Oct 2 How we calculate this

PCSA vs NTRA: Insider Trading, Funds and Congress Compared
PCSANTRA
SectorHealth CareHealth Care
Insider buys, 12 months42 ($209K)0 ($0)
Insider sales, 12 months0 ($0)101 ($235.2M)
Sales under a 10b5-1 plan099
Tracked funds holding05
Congress trades (buys)0 (0)3 (2)
5% owner filings, 12 months00
PCSA vs NTRA, daily
Loading pcsa and ntra price chart from TradingView…

Processa Pharmaceuticals, Inc. (PCSA): latest insider trades

Latest PCSA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHoldingFiling
Jul 1Jun 30Russell SkibstedCFOCFO▲ BUY3,2771.93$6K39+24%Form 4 ↗
Jul 1Jul 1George K. NgCEOCEO▲ BUY3,0571.93$6K39+25%Form 4 ↗
Jul 1Jun 30David YoungPres. Research & DevelopmentPres. Research & Development▲ BUY2,5311.93$5K23+13%Form 4 ↗
Jul 1Jun 30Wendy GuyChief Administrative OfficerChief Administrative Officer▲ BUY2,4361.93$5K34+20%Form 4 ↗
Jul 1Jun 30Patrick LinChief Business - Strategy OffChief Business - Strategy Off▲ BUY2,1061.93$4K29+19%Form 4 ↗
PCSA stock page →

Natera, Inc. (NTRA): latest insider trades

Latest NTRA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 29Oct 28Steven Leonard ChapmanCEOCEO▼ SELL10b5-13,430426.34$1.46M−3.6%Form 4 ↗
Oct 29Oct 27Steven Leonard ChapmanCEOCEO▼ SELL10b5-12,264406.00$919K−2.3%Form 4 ↗
Oct 29Oct 27Matthew RabinowitzExecutive ChairExecutive Chair▼ SELL10b5-11,718406.00$698K−0.1%Form 4 ↗
Oct 29Oct 28Michael Burkes BrophyCFOCFO▼ SELL10b5-11,198426.34$511K−2.4%Form 4 ↗
Oct 29Oct 28Solomon MoshkevichPresidentPresident▼ SELL10b5-11,162426.34$495K−1.1%Form 4 ↗
NTRA stock page →

Insider trades are open-market purchases and sales from Form 4. Fund holders are the funds we track that reported the stock on their latest 13F. 5% owners come from Schedule 13D and 13G. Price changes use weekly prices and are not adjusted for dividends.

Examples

  • Over the past 12 months insiders reported 42 purchases at PCSA and 0 at NTRA.

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.